Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Zynex, Inc. ZYXI NASDAQ

NASDAQ Global Select • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
63/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$14.38
+11404%

Zynex, Inc. (ZYXI) is a Medical - Distribution company in the Healthcare sector, currently trading at $0.13. It has a SharesGrow Score of 63/100, indicating a above average investment profile with 3 out of 7 criteria passed.

Analyst consensus target is ZYXI = $14 (+11404% upside).

Valuation: ZYXI trades at a trailing Price-to-Earnings (P/E) of -0 (S&P 500 average ~25).

Financials: revenue is $192M, +14.1%/yr average growth. Net income is $3M, growing at -37.5%/yr. Net profit margin is 1.6% (thin). Gross margin is 79.5% (+0.5 pp trend).

Balance sheet: total debt is $74M against $36M equity (Debt-to-Equity (D/E) ratio 2.07, leveraged). Current ratio is 4.46 (strong liquidity). Debt-to-assets is 60.5%. Total assets: $122M.

Analyst outlook: 6 / 9 analysts rate ZYXI as buy (67%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 48/100 (Partial), Past 100/100 (Pass), Health 33/100 (Fail), Moat 54/100 (Partial), Future 73/100 (Pass), Income 30/100 (Fail).

$14.38
▲ 11404% Upside
Average Price Target
Based on 9 Wall Street analysts offering 12-month price targets for Zynex, Inc., the average price target is $14.38, with a high forecast of $18.00, and a low forecast of $11.00.
Highest Price Target
$18.00
Average Price Target
$14.38
Lowest Price Target
$11.00

ZYXI SharesGrow Score Overview

63/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 48/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 54/100
Gross margin is + market cap
FUTURE 73/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ZYXI

✓
VALUE Pass
100/100
ZYXI trades at a trailing Price-to-Earnings (P/E) of -0 (S&P 500 average ~25). Analyst consensus target is $14, implying +11100% from the current price $0. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
48/100
ZYXI: +14.1%/yr revenue is, -37.5%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
PAST Pass
100/100
ZYXI: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
✗
HEALTH Fail
33/100
Balance sheet ZYXI: Debt-to-Equity (D/E) ratio 2.07 (leveraged), Current ratio is 4.46 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
54/100
ZYXI: Gross margin is 79.5% (+0.5 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 54/100. ≥ 70 = Pass.
View details →
✓
FUTURE Pass
73/100
Analyst outlook: 6 / 9 analysts rate ZYXI as buy (67%). Analyst consensus target is $14 (+11100% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
30/100
ZYXI: Net profit margin is 1.6%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.0312-8.45
Volume274.57K
Avg Volume (30D)7.25M
Market Cap$3.8M
Beta (1Y)1.00
Share Statistics
EPS (TTM)0.09
Shares Outstanding$31.94M
IPO Date2004-02-25
Employees1,000
CEOSteven Lewis Dyson
Financial Highlights & Ratios
Revenue (TTM)$192.35M
Gross Profit$152.93M
EBITDA$10.79M
Net Income$2.99M
Operating Income$5.99M
Total Cash$39.63M
Total Debt$73.82M
Net Debt$34.19M
Total Assets$122.08M
Price / Earnings (P/E)1.4
Price / Sales (P/S)0.02
Analyst Forecast
1Y Price Target$14.25
Target High$18.00
Target Low$11.00
Upside+11,300.0%
Rating ConsensusBuy
Analysts Covering9
Buy 67% Hold 33% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS98986M1036

Price Chart

Track all markets on TradingView
ZYXI
Zynex, Inc. ↗  ·  NASDAQ Global Select
Healthcare • Medical - Distribution
0.03 52WK RANGE 8.45

People Also View

MCK
MCK
McKesson Corporation
$862.79
-0.21%
 CAH
CAH
Cardinal Health, Inc.
$214.95
+0.36%
 ABC
ABC
AmerisourceBergen Corporation
$179.98
-0.23%
 HSIC
HSIC
Henry Schein, Inc.
$77.20
+1.59%
 PDCO
PDCO
Patterson Companies, Inc.
$31.33
-0.90%
 OMI
OMI
Owens & Minor, Inc.
$2.68
+8.94%
 EDAP
EDAP
Edap Tms S.a.
$3.30
-0.75%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message